Fiona Barry is Editor-in-Chief & Director of Outsourcing at GlobalData, where she leads the PharmSource division in gathering news, data and analysis about contract manufacturing. She has covered the pharma industry for more than a decade, as a journalist and analyst.
Archives: Speakers
George Gu 顾文兵
Head of International Cooperation, Linscope Institute for Life and Health Innovation. Over 20 years of leadership experience in multinational pharmaceutical and medical-device companies, spanning medical affairs, marketing, sales management, and strategy. Eight years as a principal consultant to global biopharma enterprises. Former oncologist at Zhongshan Hospital affiliated to Fudan University.
现任领思生命健康创新研究院 国际合作部主任。20余年跨国医药和器械公司管理,包括医学、市场、销售管理、战略等。8年跨国生物医药行业首席咨询顾问。原复旦大学附属中山医院肿瘤专业医师。
Danni Liu 刘燕清
Cherry Zhang 张婧怡
Ms Cherry Zhang joined the Australia New South Wales government in Shanghai in 2012. She is dedicated to promoting bilateral trade and investment, maintaining government relations, and facilitating cooperation across multiple fields. She provides services to businesses interested in trading and investing in Sydney and New South Wales and assists New South Wales businesses in exploring opportunities in China, introducing new products and services to the Chinese and Australian markets.
张婧怡女士于2012年加入澳大利亚新南威尔士州政府上海办公室,致力于推进双边贸易投资,维系政府关系及多领域的合作。张女士为有意在悉尼和新南威尔士州进行贸易和投资的企业提供服务,并为希望在中国寻求商机的新南威尔士州企业提供帮助,将新的产品和服务引入中国市场和澳洲市场。
Ted Chun
“With decades of experience in the healthcare industry and clinical research, Ted specializes in clinical operations, project management, data management, and innovative solutions. He also possesses a diverse management background across healthcare, life sciences, telecommunications, and aerospace. Currently he serves as regulatory and clinical consultant to three USA based medical device startup companies in Neurovascular, Cardiovascular and Orthopedic therapies and he was the leader of Stryker Neurovascular’s global clinical operations team, overseeing pre and post-market clinical studies around the world (including China). He possesses a deep understanding of global device regulations and has successfully driven the launch of numerous innovative products. “
Connor Fleet-Chapman

Vikas Agarwal
Sean D. Smith
Aditya Kotta
Aditya is the Regional Director of Business Development at Novotech, the Asia Pacific specialist CRO. He has extensive experience helping sponsor companies make their trials a reality across a range of projects from first in human to phase iv.